fda glp-1 warning letters october 2025 compounding Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the FDA Adverse Event Reporting System Compound versions of GLP-1 drugs

Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors

condoms) due to teratogenic concerns

The benefits and safety depend on the pharmacys quality and on medical oversight, since safety and ingredient consistency can vary

& Martinez-Hackert, E

BPC-157 (Body Protection Compound-157) is a synthetic gastric pentadecapeptide that has demonstrated significant tissue repair activity across preclinical models

"Liposomal systems as drug delivery vehicles for dermal and transdermal applications." Archives of Dermatological Research